Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
July 18, 2024 16:13 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum...
Gel Electrophoresis Market Insights Report, 2024-2030 - A Projected $2.5 Billion Global Market with Laboratory Research End-users Accounting for $1.2 Billion
July 18, 2024 11:42 ET
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Gel Electrophoresis - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Gel...
Tissue Engineering Market Size is Expected to Reach USD 12.43 Billion by 2032, Growing at a CAGR of 14.40%: Straits Research
July 18, 2024 10:20 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, July 18, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global tissue engineering market size was valued at USD 4,333.61 million in 2023. It is...
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA® (omadacycline) for Patients with Moderate to Severe Community-Acquired Bacterial Pneumonia
July 18, 2024 07:30 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA®
BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies
July 17, 2024 05:15 ET
|
BioProcess360
BioProcess360 Partners announce the launch of a new investment fund to support businesses with the growth of emerging bioprocessing technologies
Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice President, Technical and CMC Development
July 17, 2024 03:00 ET
|
Nouscom Srl
BASEL, Switzerland – 17th July 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today...
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
July 16, 2024 16:01 ET
|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation
July 16, 2024 11:15 ET
|
NeOnc Technologies Holdings, Inc.
FDA approval reflects positive results from Phase I and preliminary results from Phase IIa study currently underway that demonstrate increased survivability rates in patients with the IDH1...
Cell Line Development Market Size to Reach USD 16.28 Billion by 2032 with a CAGR of 9.64%: In-depth Analysis by Product, Source, Type, Applications, and Region
July 16, 2024 10:10 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, July 16, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global cell line development market size was valued at USD 6,743.00 million in 2023. It...
2024 Data Exposure Report: Life Sciences Sector Using AI to Fill Skills Gap
July 16, 2024 09:00 ET
|
Code42 Software, Inc
73% of Life Sciences companies turn to artificial intelligence (AI) to fill the cybersecurity skills gap